Block of the rapid component of the delayed rectifier potassium current by the prokinetic agent cisapride underlies drug-related lengthening of the QT interval.

BACKGROUND Lengthening of the QT interval and torsades de pointes resulting in cardiac arrests and deaths have been noticed during treatment with cisapride, a newly developed gastrointestinal prokinetic agent. The rapid (I[Kr]) and slow (I[Ks]) components of the delayed rectifier current (I[K]) are candidate ionic currents to explain cisapride-related toxicity because of their role in repolarization of cardiac ventricular myocytes. Our objectives were to (1) characterize effects of cisapride on two major time-dependent outward potassium currents involved in the repolarization of cardiac ventricular myocytes, I(Kr) and I(Ks), and (2) determine action potential-prolonging effects of cisapride on isolated hearts. METHODS AND RESULTS A first set of experiments was performed in isolated guinea pig ventricular myocytes with the whole-cell configuration of the patch-clamp technique. Cells were held at -40 mV while time-dependent outward currents were elicited by depolarizing pulses lasting either 250 ms (I[K250]) or 5000 ms (I[K5000]). Effects of cisapride on the I(Kr) component were assessed by measurement of time-dependent activating currents elicited by short pulses (250 ms; I[K250]) to low depolarizing potentials (-20, -10, and 0 mV). Time-dependent activating currents elicited by long pulses (5000 ms; I[K5000]) to positive potentials (>+30 mV) were recorded to assess effects of the drug on the I(Ks) component. A second set of experiments was conducted in isolated guinea pig hearts buffer-perfused in the Langendorff mode to assess effects of the drug on monophasic action potential duration measured at 90% repolarization (MAPD90). Hearts were exposed to cisapride 100 nmol/L at decremental pacing cycle lengths of 250, 225, 200, 175, and 150 ms to determine reverse frequency-dependent effects of the drug. Overall, 112 myocytes were exposed to seven concentrations of cisapride (10 nmol/L to 10 micromol/L). Cisapride inhibited I(Kr), the major time-dependent outward current elicited by short pulses (I[K250]) to low depolarizing potentials, in a concentration-dependent manner with an IC50 of 15 nmol/L (therapeutic levels, 50 to 200 nmol/L). Conversely, block of I(Ks) by the drug was less potent (estimated IC50 >10 micromol/L). In isolated hearts (n=9 experiments), cisapride 100 nmol/L increased MAPD90 by 23+/-3 (P<.05) at a basic cycle length of 250 ms but by only 7+/-1 ms (P<.05) at a basic cycle length of 150 ms. CONCLUSIONS Block of I(Kr) gives an explanation to lengthening of cardiac repolarization observed in isolated guinea pig hearts. Potent block of I(Kr) is also likely to underlie prolongation of the QT interval observed in patients receiving clinically recommended doses of cisapride as well as severe cardiac toxicity (torsades de pointes) observed in patients with increased plasma concentrations of the drug.

[1]  J. Houston,et al.  Comparison of ketoconazole and fluconazole as cytochrome P450 inhibitors. Use of steady-state infusion approach to achieve plasma concentration-response relationships. , 1996, Drug metabolism and disposition: the biological fate of chemicals.

[2]  D. Wortham,et al.  Terfenadine-ketoconazole interaction. Pharmacokinetic and electrocardiographic consequences. , 1993, JAMA.

[3]  P. Daleau,et al.  Triamterene inhibits the delayed rectifier potassium current (IK) in guinea pig ventricular myocytes. , 1994, Circulation research.

[4]  M. Sanguinetti,et al.  Fast inactivation causes rectification of the IKr channel , 1996, The Journal of general physiology.

[5]  D. Wysowski,et al.  Cisapride and fatal arrhythmia. , 1996, The New England journal of medicine.

[6]  C. Prakash,et al.  Cisapride. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use as a prokinetic agent in gastrointestinal motility disorders. , 1988, Drugs.

[7]  I. Edwards,et al.  Tachycardia during cisapride treatment. , 1992, BMJ.

[8]  N. Kerin,et al.  Proarrhythmia of nonantiarrhythmic drugs. , 1993, American heart journal.

[9]  M. Lewin,et al.  Cisapride-induced long QT interval. , 1996, The Journal of pediatrics.

[10]  S. Nattel,et al.  Erythromycin-induced long QT syndrome: concordance with quinidine and underlying cellular electrophysiologic mechanism. , 1990, The American journal of medicine.

[11]  StanleyNattel,et al.  Evidence for Two Components of Delayed Rectifier K+ Current in Human Ventricular Myocytes , 1996 .

[12]  E. Green,et al.  A molecular basis for cardiac arrhythmia: HERG mutations cause long QT syndrome , 1995, Cell.

[13]  L. Turnberg,et al.  Inhibition of the effect of serotonin on rat ileal transport by cisapride: evidence in favour of the involvement of 5-HT2 receptors. , 1987, Gut.

[14]  B. Dumotier,et al.  Cisapride‐induced prolongation of cardiac action potential and early afterdepolarizations in rabbit Purkinje fibres , 1996, British journal of pharmacology.

[15]  S Nattel,et al.  Evidence for two components of delayed rectifier K+ current in human ventricular myocytes. , 1996, Circulation research.

[16]  R. Clark,et al.  Cisapride-induced dysrhythmia in a pediatric patient receiving extracorporeal life support. , 1996, Critical care medicine.

[17]  H. Cooke,et al.  Pharmacological analysis of 5-hydroxytryptamine actions on guinea-pig ileal mucosa. , 1985, European journal of pharmacology.

[18]  G. Landes,et al.  Positional cloning of a novel potassium channel gene: KVLQT1 mutations cause cardiac arrhythmias , 1996, Nature Genetics.

[19]  D. Roden,et al.  Clinical features and basic mechanisms of quinidine-induced arrhythmias. , 1986, Journal of the American College of Cardiology.

[20]  W. A. Murray,et al.  Long QT syndrome during high-dose cisapride. , 1995, Archives of internal medicine.

[21]  J. Mccomb,et al.  Recurrent ventricular tachycardia associated with QT prolongation after mitral valve replacement and its association with intravenous administration of erythromycin. , 1984, The American journal of cardiology.

[22]  P. Daleau,et al.  Erythromycin blocks the rapid component of the delayed rectifier potassium current and lengthens repolarization of guinea pig ventricular myocytes. , 1995, Circulation.

[23]  M. Sanguinetti,et al.  Two components of cardiac delayed rectifier K+ current. Differential sensitivity to block by class III antiarrhythmic agents , 1990, The Journal of general physiology.

[24]  Robert G. Hauser,et al.  CARDIAC PACING AND ELECTROPHYSIOLOGY , 1986 .

[25]  B. Fermini,et al.  Rapid and slow components of delayed rectifier current in human atrial myocytes. , 1994, Cardiovascular research.

[26]  A. George,et al.  Molecular mechanism for an inherited cardiac arrhythmia , 1995, Nature.

[27]  R. McCallum.  Cisapride: a new class of prokinetic agent. The ACG Committee on FDA-related matters. American College of Gastroenterology. , 1991, The American journal of gastroenterology.

[28]  G. Gintant,et al.  Two components of delayed rectifier current in canine atrium and ventricle. Does IKs play a role in the reverse rate dependence of class III agents? , 1996, Circulation research.

[29]  W Craelius,et al.  QTU Prolongation and Polymorphic Ventricular Tachyarrhythmias Due to Bradycardia‐Dependent Early: Afterdepolarizations Afterdepolarizations and Ventricular Arrhythmias , 1988, Circulation research.

[30]  C Antzelevitch,et al.  Ionic bases for electrophysiological distinctions among epicardial, midmyocardial, and endocardial myocytes from the free wall of the canine left ventricle. , 1993, Circulation research.

[31]  J. Lynch,et al.  Cardiac electrophysiological actions of the histamine H1-receptor antagonists astemizole and terfenadine compared with chlorpheniramine and pyrilamine. , 1995, Circulation research.

[32]  C. A. Ort,et al.  Interactions between serotonin and cisapride on myenteric neurons. , 1985, European journal of pharmacology.

[33]  Arthur J Moss,et al.  SCN5A mutations associated with an inherited cardiac arrhythmia, long QT syndrome , 1995, Cell.

[34]  S Nattel,et al.  Delayed rectifier outward current and repolarization in human atrial myocytes. , 1993, Circulation research.

[35]  M. Keating,et al.  The long QT syndrome. A review of recent molecular genetic and physiologic discoveries. , 1996, Medicine.

[36]  D. Roden,et al.  Block of IKs, the slow component of the delayed rectifier K+ current, by the diuretic agent indapamide in guinea pig myocytes. , 1994, Circulation research.

[37]  Josef Schmee,et al.  An introduction to applied multivariate statistics , 1984 .